Showing results (1211-1220 of 1,243) with videos related to

Sort By:
Pageof 125
Therapeutic Innovation & Regulatory Science|June 10, 2020
Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank MeetingTrevor A Lentz, Lesley H Curtis, Frank W Rockhold, et al.
European Heart Journal|June 5, 2020
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Stefan D Anker, Javed Butler, Muhammad Shahzeb Khan, et al.
JAMA|November 17, 2023
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical TrialThomas G Stewart, Paulina A Rebolledo, Ahmad Mourad, et al.
JAMA|March 13, 2013
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trialMargaret M Redfield, Horng H Chen, Barry A Borlaug, et al.
The Canadian Journal of Cardiology|November 8, 2017
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart FailureJustin A Ezekowitz, Eileen O'Meara, Michael A McDonald, et al.
Breast Cancer Research and Treatment|June 26, 2021
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancerFoluso O Ademuyiwa, Ina Chen, Jingqin Luo, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical TrialRussell L Rothman, Thomas G Stewart, Ahmad Mourad, et al.
JAMA Network Open|October 18, 2024
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical TrialRussell L Rothman, Thomas G Stewart, Ahmad Mourad, et al.
Hypertension (Dallas, Tex. : 1979)|August 28, 2025
Overcoming Barriers to Developing and Implementing Novel Therapies for HypertensionKonstantin A Krychtiuk, Renato D Lopes, Victoria A Cargill, et al.
CJC Open|May 29, 2020
The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey, Sean A Virani, Shelley Zieroth, et al.
Pageof 125